Merontos, Chloe Belle .

HRN: 25-92-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
10/08/2024
10/15/2024
IV
21mg
Q24h
T/c Neonatal Conjunctivitis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: